Holen Sie sich die Stockscreener-App
1.50
1.96%
-0.03
Handel nachbörslich:
1.49
-0.01
-0.67%
Schlusskurs vom Vortag:
$1.53
Offen:
$1.555
24-Stunden-Volumen:
43,477
Relative Volume:
0.89
Marktkapitalisierung:
$8.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.29M
KGV:
-0.3759
EPS:
-3.99
Netto-Cashflow:
$-12.27M
1W Leistung:
-5.36%
1M Leistung:
-11.76%
6M Leistung:
-41.18%
1J Leistung:
-57.14%
1-Tages-Spanne:
$1.49
$1.555
1-Wochen-Bereich:
$1.49
$1.65
52-Wochen-Spanne:
$1.412
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Firmenname
Aprea Therapeutics Inc
Sektor
Branche
Telefon
215-948-4119
Adresse
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Vergleichen Sie APRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.50 | 9.15M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-06-22 | Eingeleitet | H.C. Wainwright | Neutral |
| 2020-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2019-10-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aprea Therapeutics Inc Aktie (APRE) Neueste Nachrichten
What’s next for Aprea Therapeutics Inc. stock priceJuly 2025 WrapUp & AI Enhanced Trading Signals - Newser
Short interest data insights for Aprea Therapeutics Inc.July 2025 Fed Impact & Verified Momentum Watchlists - Newser
What hedge funds are buying Aprea Therapeutics Inc.2025 Sector Review & Risk Controlled Stock Alerts - khodrobank.com
Is Aprea Therapeutics Inc. affected by consumer sentimentWeekly Earnings Recap & Safe Entry Momentum Stock Tips - khodrobank.com
Comparing Aprea Therapeutics Inc. in custom built stock radarsJuly 2025 Retail & Consistent Profit Trade Alerts - Newser
Tick level data insight on Aprea Therapeutics Inc. volatilityJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser
Chart based exit strategy for Aprea Therapeutics Inc.2025 Analyst Calls & Fast Moving Market Watchlists - Newser
Using R and stats models for Aprea Therapeutics Inc. forecastingWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - Newser
Can a trend reversal in Aprea Therapeutics Inc. lead to recoveryJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
Will Aprea Therapeutics Inc. benefit from geopolitical trendsMarket Sentiment Summary & Capital Protection Trade Alerts - khodrobank.com
Should you hold or exit Aprea Therapeutics Inc. nowEarnings Recap Report & Fast Moving Stock Watchlists - Newser
Aprea Therapeutics Inc. recovery potential after sell offJuly 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
How to use a screener to detect Aprea Therapeutics Inc. breakoutsBear Alert & Safe Capital Growth Stock Tips - Newser
What institutional flow reveals about Aprea Therapeutics Inc.2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
How moving averages guide Aprea Therapeutics Inc. trading2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Can technical indicators confirm Aprea Therapeutics Inc.’s reversalTrade Analysis Report & Risk Managed Trade Strategies - Newser
Identifying reversal signals in Aprea Therapeutics Inc.Market Activity Report & Growth Oriented Trade Recommendations - Newser
Price action breakdown for Aprea Therapeutics Inc.Quarterly Growth Report & Weekly High Return Opportunities - Newser
Aprea Therapeutics Inc. stock retracement – recovery analysis2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Is Aprea Therapeutics Inc. stock influenced by commodity prices2025 Momentum Check & Capital Protection Trade Alerts - khodrobank.com
What drives Aprea Therapeutics Inc.’s stock price2025 Fundamental Recap & Stock Portfolio Risk Management - khodrobank.com
Analyzing drawdowns of Aprea Therapeutics Inc. with statistical toolsDollar Strength & AI Enhanced Execution Alerts - Newser
Using Ichimoku Cloud for Aprea Therapeutics Inc. technicalsWeekly Stock Summary & Expert Verified Movement Alerts - Newser
Aprea Therapeutics Inc.’s volatility index tracking explainedPortfolio Performance Summary & Low Risk Entry Point Guides - Newser
What is Aprea Therapeutics Inc.’s market positionQuarterly Performance Summary & Community Consensus Stock Picks - خودرو بانک
Using RSI to spot recovery in Aprea Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Is Aprea Therapeutics Inc. forming a bullish divergenceQuarterly Profit Report & Weekly Setup with High ROI Potential - خودرو بانک
Trend analysis for Aprea Therapeutics Inc. this weekMarket Risk Analysis & Weekly High Return Opportunities - Newser
Visual analytics tools that track Aprea Therapeutics Inc. performanceJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - Newser
What is Aprea Therapeutics Inc.’s valuation compared to sectorMarket Sentiment Summary & Stepwise Trade Signal Implementation - khodrobank.com
Is Aprea Therapeutics Inc. stock a good pick for beginnersTrade Entry Report & Fast Entry Momentum Alerts - khodrobank.com
Analyzing Aprea Therapeutics Inc. with multi timeframe chartsJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
Aprea Therapeutics Inc. stock daily chart insightsMarket Movers & AI Enhanced Execution Alerts - Newser
Real time breakdown of Aprea Therapeutics Inc. stock performanceMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - Newser
Market reaction to Aprea Therapeutics Inc.’s recent newsQuarterly Profit Review & Low Risk Entry Point Guides - Newser
Volatility clustering patterns for Aprea Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Multi factor analysis applied to Aprea Therapeutics Inc.2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aprea Therapeutics Inc-Aktie (APRE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Duey Marc | Director |
Oct 18 '24 |
Sale |
4.58 |
6,462 |
29,583 |
233,651 |
| Gilad Oren | President/CEO |
Oct 23 '24 |
Buy |
3.92 |
500 |
1,958 |
333,395 |
| Duey Marc | Director |
Oct 16 '24 |
Buy |
4.39 |
30,000 |
131,700 |
240,113 |
| Gilad Oren | President/CEO |
Oct 15 '24 |
Buy |
2.90 |
250 |
725 |
332,895 |
| Duey Marc | Director |
Oct 14 '24 |
Buy |
2.58 |
190 |
490 |
210,113 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr |
Oct 11 '24 |
Buy |
2.46 |
50 |
123 |
19,368 |
| Seizinger Bernd R. | Director |
Oct 11 '24 |
Buy |
2.68 |
10,000 |
26,800 |
44,730 |
| Gilad Oren | President/CEO |
Oct 14 '24 |
Buy |
2.59 |
1,000 |
2,590 |
332,645 |
| Gilad Oren | President/CEO |
Oct 10 '24 |
Buy |
2.54 |
150 |
381 |
331,645 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr |
Oct 10 '24 |
Buy |
2.61 |
450 |
1,174 |
19,318 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):